Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders
Daniel M. Chopyk, Arash Grakoui
Gastroenterology (2020) Vol. 159, Iss. 3, pp. 849-863
Open Access | Times Cited: 315

Showing 1-25 of 315 citing articles:

Gut microbiome, liver immunology, and liver diseases
Rui Wang, Ruqi Tang, Bo Li, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 1, pp. 4-17
Open Access | Times Cited: 299
Hepatic inflammatory responses in liver fibrosis
Linda Hammerich, Frank Tacke
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 10, pp. 633-646
Closed Access | Times Cited: 291
The Role of Intestinal Permeability in Gastrointestinal Disorders and Current Methods of Evaluation
Tim Vanuytsel, Jan Tack, Ricard Farré
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 148
Baicalin and the liver-gut system: Pharmacological bases explaining its therapeutic effects
Qichao Hu, Wenwen Zhang, Zhao Wu, et al.
Pharmacological Research (2021) Vol. 165, pp. 105444-105444
Closed Access | Times Cited: 147
Akkermansia muciniphila Ameliorates Acetaminophen-Induced Liver Injury by Regulating Gut Microbial Composition and Metabolism
Jiafeng Xia, Longxian Lv, Boqiang Liu, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 115
Melatonin mitigates aflatoxin B1‐induced liver injury via modulation of gut microbiota/intestinal FXR/liver TLR4 signaling axis in mice
Shuiping Liu, Weili Kang, Xinru Mao, et al.
Journal of Pineal Research (2022) Vol. 73, Iss. 2
Closed Access | Times Cited: 108
Altered Gut Microbiome Composition and Function Are Associated With Gut Barrier Dysfunction in Healthy Relatives of Patients With Crohn’s Disease
Haim Leibovitzh, Sun-Ho Lee, Mingyue Xue, et al.
Gastroenterology (2022) Vol. 163, Iss. 5, pp. 1364-1376.e10
Open Access | Times Cited: 105
Mitochondria: It is all about energy
Amaloha Casanova, Anne Wevers, Santiago Navarro‐Ledesma, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 95
Chronic exposure to polyvinyl chloride microplastics induces liver injury and gut microbiota dysbiosis based on the integration of liver transcriptome profiles and full-length 16S rRNA sequencing data
Xuebing Chen, Jingshen Zhuang, Qianling Chen, et al.
The Science of The Total Environment (2022) Vol. 839, pp. 155984-155984
Closed Access | Times Cited: 83
Risk of Heart Failure in Patients With Nonalcoholic Fatty Liver Disease
Alessandro Mantovani, Christopher D. Byrne, Giovanni Benfari, et al.
Journal of the American College of Cardiology (2022) Vol. 79, Iss. 2, pp. 180-191
Open Access | Times Cited: 80
Small Intestinal Bacterial Overgrowth—Pathophysiology and Its Implications for Definition and Management
Daniel Bushyhead, Eamonn M.M. Quigley
Gastroenterology (2022) Vol. 163, Iss. 3, pp. 593-607
Open Access | Times Cited: 78
Gut liver brain axis in diseases: the implications for therapeutic interventions
Mengyao Yan, Shuli Man, Benyue Sun, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 78
Gut microbiota remodeling improves natural aging-related disorders through Akkermansia muciniphila and its derived acetic acid
Junli Ma, Zekun Liu, Xinxin Gao, et al.
Pharmacological Research (2023) Vol. 189, pp. 106687-106687
Open Access | Times Cited: 73
Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFLD
Ekaterina Smirnova, Mark Muthiah, Nicole Narayan, et al.
Hepatology (2022) Vol. 76, Iss. 6, pp. 1811-1824
Open Access | Times Cited: 70
Pregnancy-induced changes to the gut microbiota drive macrophage pyroptosis and exacerbate septic inflammation
Xia Chen, Rong Wu, Lei Li, et al.
Immunity (2023) Vol. 56, Iss. 2, pp. 336-352.e9
Open Access | Times Cited: 65
Probiotics fortify intestinal barrier function: a systematic review and meta-analysis of randomized trials
Yanfei Zheng, Zengliang Zhang, Ping Tang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 65
The role of gut microbiota in intestinal disease: from an oxidative stress perspective
Yiqi Sun, Xurui Wang, Lei Li, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 32
Chronic arsenic exposure-provoked biotoxicity involved in liver-microbiota-gut axis disruption in chickens based on multi-omics technologies
Jiayi Li, Changming Guo, Yan Liu, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 18
Lactic acid fermentation of goji berries (Lycium barbarum) prevents acute alcohol liver injury and modulates gut microbiota and metabolites in mice
Wenhui Duan, Lingxi Zhou, Yilin Ren, et al.
Food & Function (2024) Vol. 15, Iss. 3, pp. 1612-1626
Closed Access | Times Cited: 16
Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases
Susana Rodrigues, Van der Merwe, Aleksander Krag, et al.
Seminars in Immunology (2024) Vol. 71, pp. 101859-101859
Open Access | Times Cited: 16
Liver Fibrosis: From Basic Science towards Clinical Progress, Focusing on the Central Role of Hepatic Stellate Cells
Hikmet Akkız, Robert K. Gieseler, Ali Canbay
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7873-7873
Open Access | Times Cited: 15
NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment
Giovanni Targher, Kathleen E. Corey, Christopher D. Byrne
Diabetes & Metabolism (2020) Vol. 47, Iss. 2, pp. 101215-101215
Open Access | Times Cited: 131
The Gut Barrier, Intestinal Microbiota, and Liver Disease: Molecular Mechanisms and Strategies to Manage
Julio Plaza‐Díaz, Patricio Solis‐Urra, Fernando Rodríguez‐Rodríguez, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8351-8351
Open Access | Times Cited: 99
Effect of different bile acids on the intestine through enterohepatic circulation based on FXR
Junwei Xiang, Zhengyan Zhang, Hong-Yi Xie, et al.
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 77
A review on gut microbiota: a central factor in the pathophysiology of obesity
Andrew Cunningham, J. W. Stephens, Dean Harris
Lipids in Health and Disease (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 69
Page 1 - Next Page

Scroll to top